Healthy adults needed to test new Drug's safety
NCT ID NCT07136103
First seen Sep 30, 2025 · Last updated May 01, 2026 · Updated 27 times
Summary
This early-stage study is testing a new drug called ABBV-277 in 32 healthy adults. The main goal is to see if it is safe and how the body handles a single dose. Participants will not receive any direct treatment benefit, but the results will help guide future research.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Acpru /Id# 265681
Grayslake, Illinois, 60030, United States
Conditions
Explore the condition pages connected to this study.